Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050762 · ClinicalTrials.gov registry record
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
A clinical trial of Endocrine Disease, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT03050762: Recruiting study of Endocrine Disease, sponsored by M.D. Anderson Cancer Center.
NCT03050762 is a study of Endocrine Disease that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 15,000 participants, above the 1,029-participant average among 4 other Endocrine Disease trials with a reported enrollment target (1358% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03050762, a study of Endocrine Disease, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
Primary Outcome
Database compiled from continuous collection of data on patients diagnosed with surgical endocrine disease or patients who are at risk for developing endocrine neoplasia and/or disease, and by prospective follow-ups of patient populations.
Conditions Studied
Interventions
- OTHER Data Collection
- BEHAVIORAL Follow Up
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2011-10-05 |
| Est. Completion | 2027-10 |
What NCT03050762 shows while recruiting
NCT03050762 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,029-participant average among 4 other Endocrine Disease trials with a reported enrollment target (1358% higher).
The record links to 1 condition, with Endocrine Disease appearing as the primary indexed condition, and to 2 interventions - of which Data Collection is the first listed.
NCT03050762 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03050762 about?
NCT03050762 is a clinical study titled "Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease". The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
What is the current status of trial NCT03050762?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2011-10-05. Estimated completion is 2027-10.
What conditions does trial NCT03050762 study?
This clinical trial studies the following conditions: Endocrine Disease.
What interventions are being tested in trial NCT03050762?
The interventions under investigation include: Data Collection (OTHER), Follow Up (BEHAVIORAL).
Who is sponsoring clinical trial NCT03050762?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03050762 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endocrine Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Endocrine-Related Conditions and Physiology
RECRUITING
-
Diagnosis of Pheochromocytoma
RECRUITING · Phase 1
-
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
COMPLETED · Phase 2
-
Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI